LINDSAY FRAZIER: Open Payments
NPI 1063749992 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,437 in 173 payments from 18 companies in 2025. Trend: 2023 $26,512 · 2024 $20,607 · 2025 $35,437
Speaker / faculty: $21,583Travel & lodging: $9,678Food & beverage: $2,970Consulting: $1,125Education: $81
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 23 | $17,925 |
| Regeneron Healthcare Solutions, Inc. | 36 | $14,847 |
| Janssen Biotech, Inc. | 4 | $1,309 |
| Novartis Pharmaceuticals Corporation | 10 | $229 |
| UCB, Inc. | 21 | $209 |
| REVANCE THERAPEUTICS, INC. | 7 | $204 |
| Arcutis Biotherapeutics, Inc. | 19 | $165 |
| E.R. Squibb & Sons, L.L.C. | 35 | $164 |
| Incyte Corporation | 3 | $79 |
| ABBVIE INC. | 3 | $77 |
Products named: DUPIXENT, TREMFYA, Bimzelx, COSENTYX, DAXXIFY, Zoryve, Sotyktu, OPZELURA.
Industry payments across TN — which companies pay providers there.
